- Home
- BBD vs BDX Comparison
BBD vs BDX Comparison
Compare BBD & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBD | BDX |
|---|---|---|
| Founded | 1943 | 1897 |
| Country | Brazil | United States |
| Employees | 80348 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3B | 43.0B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | BBD | BDX |
|---|---|---|
| Price | $3.69 | $158.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 13 |
| Target Price | N/A | ★ $186.00 |
| AVG Volume (30 Days) | ★ 33.3M | 1.7M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.82% | 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $70.86 | N/A |
| Revenue Next Year | $8.33 | $3.02 |
| P/E Ratio | ★ $9.20 | $635.68 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $2.73 | $140.11 |
| 52 Week High | $4.30 | $213.08 |
Technical Indicators
Market Signals| Indicator | BBD | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 58.03 | 64.92 |
| Support Level | $3.41 | $163.44 |
| Resistance Level | $3.74 | $195.18 |
| Average True Range (ATR) | 0.07 | 3.57 |
| MACD | 0.01 | 0.56 |
| Stochastic Oscillator | 81.22 | 99.37 |
Price Performance
Historical ComparisonAbout BBD Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation, a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.